FDA Allows Novel Treatment for Migraine
The Food and Drug Administration has given green signal for a novel treatment of migraine-related nausea and headache taking place due to migraine. The Zecuity skin patch system is meant to provide relief to people suffering from migraine.
Experts said that they have been expecting that a lot of Americans will be benefitted from the skin patch which works with a single use battery. As per official statistics, out of 16 million US people suffering from migraine, eight million people are the ones who witness migraine-related nausea.
"In addition to severe headache pain, migraine patients [come in] with other significant symptoms, which commonly include migraine-related nausea", said Lawrence C. Newman director at St. Luke's-Roosevelt Hospital, New York.
The skin patch can either be applied on the upper arm or on the thigh and then the patch is to be put on at the active mode by which medicine gets delivered through the skin. It has been found that the skin patch is able to deliver
6.5 milligrams of dosage in four hours.
The company has carried out clinical trials on 800 migraine patients, who have used thousands of patches. The treatment is said to be safe and effective in reducing migraine related pain and is also quite effective in reducing sensitivity towards light and sound.